nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—ABCB1—kidney cancer	0.215	1	CbGaD
Levomilnacipran—ABCB1—Temsirolimus—kidney cancer	0.0424	0.0789	CbGbCtD
Levomilnacipran—CYP2D6—Temsirolimus—kidney cancer	0.0399	0.0744	CbGbCtD
Levomilnacipran—CYP3A4—Everolimus—kidney cancer	0.0376	0.07	CbGbCtD
Levomilnacipran—CYP2C8—Pazopanib—kidney cancer	0.0329	0.0613	CbGbCtD
Levomilnacipran—CYP3A4—Temsirolimus—kidney cancer	0.0254	0.0473	CbGbCtD
Levomilnacipran—CYP2C8—Erlotinib—kidney cancer	0.0235	0.0437	CbGbCtD
Levomilnacipran—ABCB1—Pazopanib—kidney cancer	0.0223	0.0415	CbGbCtD
Levomilnacipran—CYP2C8—Paclitaxel—kidney cancer	0.0215	0.04	CbGbCtD
Levomilnacipran—CYP2D6—Pazopanib—kidney cancer	0.021	0.0391	CbGbCtD
Levomilnacipran—ABCB1—Dactinomycin—kidney cancer	0.0204	0.0379	CbGbCtD
Levomilnacipran—CYP2C8—Sorafenib—kidney cancer	0.0191	0.0355	CbGbCtD
Levomilnacipran—ABCB1—Gemcitabine—kidney cancer	0.0161	0.03	CbGbCtD
Levomilnacipran—CYP2C19—Sorafenib—kidney cancer	0.016	0.0298	CbGbCtD
Levomilnacipran—ABCB1—Erlotinib—kidney cancer	0.0159	0.0296	CbGbCtD
Levomilnacipran—CYP2D6—Erlotinib—kidney cancer	0.015	0.0279	CbGbCtD
Levomilnacipran—ABCB1—Paclitaxel—kidney cancer	0.0145	0.0271	CbGbCtD
Levomilnacipran—CYP3A4—Pazopanib—kidney cancer	0.0133	0.0248	CbGbCtD
Levomilnacipran—ABCB1—Sorafenib—kidney cancer	0.0129	0.0241	CbGbCtD
Levomilnacipran—ABCB1—Vinblastine—kidney cancer	0.0128	0.0238	CbGbCtD
Levomilnacipran—ABCB1—Vincristine—kidney cancer	0.0125	0.0234	CbGbCtD
Levomilnacipran—CYP2D6—Sorafenib—kidney cancer	0.0122	0.0227	CbGbCtD
Levomilnacipran—CYP2D6—Vinblastine—kidney cancer	0.012	0.0224	CbGbCtD
Levomilnacipran—ABCB1—Sunitinib—kidney cancer	0.0105	0.0195	CbGbCtD
Levomilnacipran—CYP3A4—Erlotinib—kidney cancer	0.00952	0.0177	CbGbCtD
Levomilnacipran—CYP3A4—Paclitaxel—kidney cancer	0.00871	0.0162	CbGbCtD
Levomilnacipran—ABCB1—Doxorubicin—kidney cancer	0.00784	0.0146	CbGbCtD
Levomilnacipran—CYP3A4—Sorafenib—kidney cancer	0.00774	0.0144	CbGbCtD
Levomilnacipran—CYP3A4—Vinblastine—kidney cancer	0.00764	0.0142	CbGbCtD
Levomilnacipran—CYP3A4—Vincristine—kidney cancer	0.00751	0.014	CbGbCtD
Levomilnacipran—CYP2D6—Doxorubicin—kidney cancer	0.00738	0.0138	CbGbCtD
Levomilnacipran—CYP3A4—Sunitinib—kidney cancer	0.00627	0.0117	CbGbCtD
Levomilnacipran—CYP3A4—Doxorubicin—kidney cancer	0.0047	0.00875	CbGbCtD
Levomilnacipran—CYP2C19—urine—kidney cancer	0.000931	0.201	CbGeAlD
Levomilnacipran—CYP2J2—nephron tubule—kidney cancer	0.000561	0.121	CbGeAlD
Levomilnacipran—CYP3A4—urine—kidney cancer	0.00055	0.119	CbGeAlD
Levomilnacipran—CYP2D6—urine—kidney cancer	0.000542	0.117	CbGeAlD
Levomilnacipran—CYP2J2—cardiac atrium—kidney cancer	0.000457	0.0984	CbGeAlD
Levomilnacipran—SLC6A2—gonad—kidney cancer	0.000217	0.0468	CbGeAlD
Levomilnacipran—CYP2C8—renal system—kidney cancer	0.000199	0.0428	CbGeAlD
Levomilnacipran—CYP2C8—kidney—kidney cancer	0.000192	0.0414	CbGeAlD
Levomilnacipran—Connective tissue disorder—Capecitabine—kidney cancer	0.000152	0.000748	CcSEcCtD
Levomilnacipran—Vomiting—Everolimus—kidney cancer	0.000151	0.000747	CcSEcCtD
Levomilnacipran—Urethral disorder—Capecitabine—kidney cancer	0.000151	0.000746	CcSEcCtD
Levomilnacipran—Paraesthesia—Vincristine—kidney cancer	0.000151	0.000745	CcSEcCtD
Levomilnacipran—Agitation—Paclitaxel—kidney cancer	0.00015	0.000742	CcSEcCtD
Levomilnacipran—Rash—Everolimus—kidney cancer	0.00015	0.00074	CcSEcCtD
Levomilnacipran—Dermatitis—Everolimus—kidney cancer	0.00015	0.00074	CcSEcCtD
Levomilnacipran—Headache—Vinblastine—kidney cancer	0.00015	0.000738	CcSEcCtD
Levomilnacipran—Headache—Everolimus—kidney cancer	0.000149	0.000736	CcSEcCtD
Levomilnacipran—Hypotension—Gemcitabine—kidney cancer	0.000149	0.000735	CcSEcCtD
Levomilnacipran—Body temperature increased—Dactinomycin—kidney cancer	0.000149	0.000734	CcSEcCtD
Levomilnacipran—Abdominal pain—Dactinomycin—kidney cancer	0.000149	0.000734	CcSEcCtD
Levomilnacipran—Asthenia—Sorafenib—kidney cancer	0.000148	0.000731	CcSEcCtD
Levomilnacipran—Syncope—Paclitaxel—kidney cancer	0.000147	0.000724	CcSEcCtD
Levomilnacipran—Leukopenia—Paclitaxel—kidney cancer	0.000146	0.000723	CcSEcCtD
Levomilnacipran—Hypersensitivity—Sunitinib—kidney cancer	0.000146	0.000723	CcSEcCtD
Levomilnacipran—Decreased appetite—Vincristine—kidney cancer	0.000146	0.000721	CcSEcCtD
Levomilnacipran—Pruritus—Sorafenib—kidney cancer	0.000146	0.000721	CcSEcCtD
Levomilnacipran—Vomiting—Erlotinib—kidney cancer	0.000146	0.00072	CcSEcCtD
Levomilnacipran—Erythema multiforme—Capecitabine—kidney cancer	0.000146	0.00072	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Vincristine—kidney cancer	0.000145	0.000716	CcSEcCtD
Levomilnacipran—Fatigue—Vincristine—kidney cancer	0.000145	0.000715	CcSEcCtD
Levomilnacipran—Rash—Erlotinib—kidney cancer	0.000145	0.000714	CcSEcCtD
Levomilnacipran—Dermatitis—Erlotinib—kidney cancer	0.000145	0.000714	CcSEcCtD
Levomilnacipran—Palpitations—Paclitaxel—kidney cancer	0.000145	0.000713	CcSEcCtD
Levomilnacipran—Hyponatraemia—Doxorubicin—kidney cancer	0.000144	0.000712	CcSEcCtD
Levomilnacipran—Insomnia—Gemcitabine—kidney cancer	0.000144	0.000712	CcSEcCtD
Levomilnacipran—Eye disorder—Capecitabine—kidney cancer	0.000144	0.000711	CcSEcCtD
Levomilnacipran—Headache—Erlotinib—kidney cancer	0.000144	0.00071	CcSEcCtD
Levomilnacipran—Loss of consciousness—Paclitaxel—kidney cancer	0.000144	0.00071	CcSEcCtD
Levomilnacipran—Constipation—Vincristine—kidney cancer	0.000144	0.000709	CcSEcCtD
Levomilnacipran—Paraesthesia—Gemcitabine—kidney cancer	0.000143	0.000707	CcSEcCtD
Levomilnacipran—Cardiac disorder—Capecitabine—kidney cancer	0.000143	0.000706	CcSEcCtD
Levomilnacipran—Flushing—Capecitabine—kidney cancer	0.000143	0.000706	CcSEcCtD
Levomilnacipran—Asthenia—Sunitinib—kidney cancer	0.000143	0.000704	CcSEcCtD
Levomilnacipran—Dyspnoea—Gemcitabine—kidney cancer	0.000142	0.000702	CcSEcCtD
Levomilnacipran—Nausea—Vinblastine—kidney cancer	0.000142	0.0007	CcSEcCtD
Levomilnacipran—Somnolence—Gemcitabine—kidney cancer	0.000142	0.0007	CcSEcCtD
Levomilnacipran—Convulsion—Paclitaxel—kidney cancer	0.000142	0.000699	CcSEcCtD
Levomilnacipran—Migraine—Doxorubicin—kidney cancer	0.000141	0.000698	CcSEcCtD
Levomilnacipran—Nausea—Everolimus—kidney cancer	0.000141	0.000697	CcSEcCtD
Levomilnacipran—Diarrhoea—Sorafenib—kidney cancer	0.000141	0.000697	CcSEcCtD
Levomilnacipran—Hypertension—Paclitaxel—kidney cancer	0.000141	0.000697	CcSEcCtD
Levomilnacipran—Pruritus—Sunitinib—kidney cancer	0.000141	0.000694	CcSEcCtD
Levomilnacipran—Angiopathy—Capecitabine—kidney cancer	0.00014	0.00069	CcSEcCtD
Levomilnacipran—Chest pain—Paclitaxel—kidney cancer	0.000139	0.000687	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Capecitabine—kidney cancer	0.000139	0.000686	CcSEcCtD
Levomilnacipran—Anxiety—Paclitaxel—kidney cancer	0.000139	0.000685	CcSEcCtD
Levomilnacipran—Decreased appetite—Gemcitabine—kidney cancer	0.000139	0.000684	CcSEcCtD
Levomilnacipran—Hypersensitivity—Dactinomycin—kidney cancer	0.000139	0.000684	CcSEcCtD
Levomilnacipran—Chills—Capecitabine—kidney cancer	0.000138	0.000683	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000138	0.000683	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000138	0.000679	CcSEcCtD
Levomilnacipran—Fatigue—Gemcitabine—kidney cancer	0.000137	0.000678	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Vincristine—kidney cancer	0.000137	0.000678	CcSEcCtD
Levomilnacipran—Dizziness—Sorafenib—kidney cancer	0.000137	0.000674	CcSEcCtD
Levomilnacipran—Constipation—Gemcitabine—kidney cancer	0.000136	0.000673	CcSEcCtD
Levomilnacipran—Nausea—Erlotinib—kidney cancer	0.000136	0.000673	CcSEcCtD
Levomilnacipran—Dry mouth—Paclitaxel—kidney cancer	0.000136	0.000672	CcSEcCtD
Levomilnacipran—Diarrhoea—Sunitinib—kidney cancer	0.000136	0.000671	CcSEcCtD
Levomilnacipran—Mental disorder—Capecitabine—kidney cancer	0.000135	0.000667	CcSEcCtD
Levomilnacipran—Asthenia—Dactinomycin—kidney cancer	0.000135	0.000666	CcSEcCtD
Levomilnacipran—CYP3A4—renal system—kidney cancer	0.000135	0.029	CbGeAlD
Levomilnacipran—Malnutrition—Capecitabine—kidney cancer	0.000134	0.000663	CcSEcCtD
Levomilnacipran—Abdominal pain—Vincristine—kidney cancer	0.000133	0.000656	CcSEcCtD
Levomilnacipran—Body temperature increased—Vincristine—kidney cancer	0.000133	0.000656	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Doxorubicin—kidney cancer	0.000133	0.000655	CcSEcCtD
Levomilnacipran—Infection—Paclitaxel—kidney cancer	0.000133	0.000655	CcSEcCtD
Levomilnacipran—CYP2D6—renal system—kidney cancer	0.000133	0.0285	CbGeAlD
Levomilnacipran—Flatulence—Capecitabine—kidney cancer	0.000132	0.000653	CcSEcCtD
Levomilnacipran—Dry skin—Doxorubicin—kidney cancer	0.000132	0.00065	CcSEcCtD
Levomilnacipran—Dysgeusia—Capecitabine—kidney cancer	0.000131	0.000649	CcSEcCtD
Levomilnacipran—Dizziness—Sunitinib—kidney cancer	0.000131	0.000649	CcSEcCtD
Levomilnacipran—Shock—Paclitaxel—kidney cancer	0.000131	0.000648	CcSEcCtD
Levomilnacipran—Vomiting—Sorafenib—kidney cancer	0.000131	0.000648	CcSEcCtD
Levomilnacipran—Nervous system disorder—Paclitaxel—kidney cancer	0.000131	0.000646	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Paclitaxel—kidney cancer	0.000131	0.000645	CcSEcCtD
Levomilnacipran—Tachycardia—Paclitaxel—kidney cancer	0.00013	0.000643	CcSEcCtD
Levomilnacipran—Rash—Sorafenib—kidney cancer	0.00013	0.000643	CcSEcCtD
Levomilnacipran—CYP3A4—kidney—kidney cancer	0.00013	0.028	CbGeAlD
Levomilnacipran—Dermatitis—Sorafenib—kidney cancer	0.00013	0.000642	CcSEcCtD
Levomilnacipran—Breast disorder—Doxorubicin—kidney cancer	0.00013	0.000641	CcSEcCtD
Levomilnacipran—Skin disorder—Paclitaxel—kidney cancer	0.00013	0.00064	CcSEcCtD
Levomilnacipran—Headache—Sorafenib—kidney cancer	0.000129	0.000639	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Paclitaxel—kidney cancer	0.000129	0.000637	CcSEcCtD
Levomilnacipran—Diarrhoea—Dactinomycin—kidney cancer	0.000129	0.000635	CcSEcCtD
Levomilnacipran—CYP2D6—kidney—kidney cancer	0.000128	0.0276	CbGeAlD
Levomilnacipran—Anorexia—Paclitaxel—kidney cancer	0.000127	0.000628	CcSEcCtD
Levomilnacipran—Vision blurred—Capecitabine—kidney cancer	0.000127	0.000624	CcSEcCtD
Levomilnacipran—Vomiting—Sunitinib—kidney cancer	0.000126	0.000624	CcSEcCtD
Levomilnacipran—Body temperature increased—Gemcitabine—kidney cancer	0.000126	0.000622	CcSEcCtD
Levomilnacipran—Tremor—Capecitabine—kidney cancer	0.000126	0.000621	CcSEcCtD
Levomilnacipran—Rash—Sunitinib—kidney cancer	0.000125	0.000618	CcSEcCtD
Levomilnacipran—Dermatitis—Sunitinib—kidney cancer	0.000125	0.000618	CcSEcCtD
Levomilnacipran—Abdominal distension—Doxorubicin—kidney cancer	0.000125	0.000617	CcSEcCtD
Levomilnacipran—Hypotension—Paclitaxel—kidney cancer	0.000125	0.000616	CcSEcCtD
Levomilnacipran—Headache—Sunitinib—kidney cancer	0.000124	0.000614	CcSEcCtD
Levomilnacipran—Hypersensitivity—Vincristine—kidney cancer	0.000124	0.000611	CcSEcCtD
Levomilnacipran—Nausea—Sorafenib—kidney cancer	0.000123	0.000605	CcSEcCtD
Levomilnacipran—Angina pectoris—Doxorubicin—kidney cancer	0.000121	0.000597	CcSEcCtD
Levomilnacipran—Insomnia—Paclitaxel—kidney cancer	0.000121	0.000596	CcSEcCtD
Levomilnacipran—Asthenia—Vincristine—kidney cancer	0.000121	0.000595	CcSEcCtD
Levomilnacipran—Syncope—Capecitabine—kidney cancer	0.00012	0.000594	CcSEcCtD
Levomilnacipran—Leukopenia—Capecitabine—kidney cancer	0.00012	0.000593	CcSEcCtD
Levomilnacipran—Paraesthesia—Paclitaxel—kidney cancer	0.00012	0.000592	CcSEcCtD
Levomilnacipran—Vomiting—Dactinomycin—kidney cancer	0.00012	0.00059	CcSEcCtD
Levomilnacipran—Dyspnoea—Paclitaxel—kidney cancer	0.000119	0.000587	CcSEcCtD
Levomilnacipran—Somnolence—Paclitaxel—kidney cancer	0.000119	0.000586	CcSEcCtD
Levomilnacipran—Palpitations—Capecitabine—kidney cancer	0.000119	0.000585	CcSEcCtD
Levomilnacipran—Rash—Dactinomycin—kidney cancer	0.000119	0.000585	CcSEcCtD
Levomilnacipran—Nausea—Sunitinib—kidney cancer	0.000118	0.000583	CcSEcCtD
Levomilnacipran—Loss of consciousness—Capecitabine—kidney cancer	0.000118	0.000582	CcSEcCtD
Levomilnacipran—Dyspepsia—Paclitaxel—kidney cancer	0.000118	0.00058	CcSEcCtD
Levomilnacipran—Dysuria—Doxorubicin—kidney cancer	0.000116	0.000573	CcSEcCtD
Levomilnacipran—Neutropenia—Doxorubicin—kidney cancer	0.000116	0.000573	CcSEcCtD
Levomilnacipran—Decreased appetite—Paclitaxel—kidney cancer	0.000116	0.000573	CcSEcCtD
Levomilnacipran—Hypertension—Capecitabine—kidney cancer	0.000116	0.000572	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000115	0.00057	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000115	0.000569	CcSEcCtD
Levomilnacipran—Fatigue—Paclitaxel—kidney cancer	0.000115	0.000568	CcSEcCtD
Levomilnacipran—Diarrhoea—Vincristine—kidney cancer	0.000115	0.000568	CcSEcCtD
Levomilnacipran—Pollakiuria—Doxorubicin—kidney cancer	0.000115	0.000566	CcSEcCtD
Levomilnacipran—Asthenia—Gemcitabine—kidney cancer	0.000114	0.000565	CcSEcCtD
Levomilnacipran—Chest pain—Capecitabine—kidney cancer	0.000114	0.000564	CcSEcCtD
Levomilnacipran—Constipation—Paclitaxel—kidney cancer	0.000114	0.000563	CcSEcCtD
Levomilnacipran—Anxiety—Capecitabine—kidney cancer	0.000114	0.000562	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000113	0.00056	CcSEcCtD
Levomilnacipran—Pruritus—Gemcitabine—kidney cancer	0.000113	0.000557	CcSEcCtD
Levomilnacipran—Weight decreased—Doxorubicin—kidney cancer	0.000112	0.000555	CcSEcCtD
Levomilnacipran—Dry mouth—Capecitabine—kidney cancer	0.000112	0.000552	CcSEcCtD
Levomilnacipran—Nausea—Dactinomycin—kidney cancer	0.000112	0.000552	CcSEcCtD
Levomilnacipran—Dizziness—Vincristine—kidney cancer	0.000111	0.000549	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00011	0.000542	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000109	0.000539	CcSEcCtD
Levomilnacipran—Diarrhoea—Gemcitabine—kidney cancer	0.000109	0.000538	CcSEcCtD
Levomilnacipran—Infection—Capecitabine—kidney cancer	0.000109	0.000537	CcSEcCtD
Levomilnacipran—Shock—Capecitabine—kidney cancer	0.000108	0.000532	CcSEcCtD
Levomilnacipran—Urinary tract infection—Doxorubicin—kidney cancer	0.000108	0.000531	CcSEcCtD
Levomilnacipran—Nervous system disorder—Capecitabine—kidney cancer	0.000107	0.00053	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Capecitabine—kidney cancer	0.000107	0.000529	CcSEcCtD
Levomilnacipran—Tachycardia—Capecitabine—kidney cancer	0.000107	0.000528	CcSEcCtD
Levomilnacipran—Vomiting—Vincristine—kidney cancer	0.000107	0.000527	CcSEcCtD
Levomilnacipran—Skin disorder—Capecitabine—kidney cancer	0.000106	0.000525	CcSEcCtD
Levomilnacipran—Urticaria—Paclitaxel—kidney cancer	0.000106	0.000523	CcSEcCtD
Levomilnacipran—Rash—Vincristine—kidney cancer	0.000106	0.000523	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Capecitabine—kidney cancer	0.000106	0.000523	CcSEcCtD
Levomilnacipran—Dermatitis—Vincristine—kidney cancer	0.000106	0.000523	CcSEcCtD
Levomilnacipran—Haematuria—Doxorubicin—kidney cancer	0.000106	0.000521	CcSEcCtD
Levomilnacipran—Body temperature increased—Paclitaxel—kidney cancer	0.000106	0.000521	CcSEcCtD
Levomilnacipran—Abdominal pain—Paclitaxel—kidney cancer	0.000106	0.000521	CcSEcCtD
Levomilnacipran—Headache—Vincristine—kidney cancer	0.000105	0.00052	CcSEcCtD
Levomilnacipran—ABCB1—nephron tubule—kidney cancer	0.000105	0.0226	CbGeAlD
Levomilnacipran—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000105	0.000517	CcSEcCtD
Levomilnacipran—Anorexia—Capecitabine—kidney cancer	0.000104	0.000515	CcSEcCtD
Levomilnacipran—Hypotension—Capecitabine—kidney cancer	0.000102	0.000505	CcSEcCtD
Levomilnacipran—Vomiting—Gemcitabine—kidney cancer	0.000101	0.0005	CcSEcCtD
Levomilnacipran—Rash—Gemcitabine—kidney cancer	0.000101	0.000496	CcSEcCtD
Levomilnacipran—Dermatitis—Gemcitabine—kidney cancer	0.0001	0.000496	CcSEcCtD
Levomilnacipran—Headache—Gemcitabine—kidney cancer	9.99e-05	0.000493	CcSEcCtD
Levomilnacipran—Nausea—Vincristine—kidney cancer	9.98e-05	0.000493	CcSEcCtD
Levomilnacipran—Hepatitis—Doxorubicin—kidney cancer	9.94e-05	0.000491	CcSEcCtD
Levomilnacipran—Insomnia—Capecitabine—kidney cancer	9.91e-05	0.000489	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Doxorubicin—kidney cancer	9.89e-05	0.000488	CcSEcCtD
Levomilnacipran—Paraesthesia—Capecitabine—kidney cancer	9.84e-05	0.000486	CcSEcCtD
Levomilnacipran—Hypersensitivity—Paclitaxel—kidney cancer	9.84e-05	0.000485	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Doxorubicin—kidney cancer	9.82e-05	0.000484	CcSEcCtD
Levomilnacipran—Oedema peripheral—Doxorubicin—kidney cancer	9.79e-05	0.000483	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Doxorubicin—kidney cancer	9.77e-05	0.000482	CcSEcCtD
Levomilnacipran—Dyspnoea—Capecitabine—kidney cancer	9.77e-05	0.000482	CcSEcCtD
Levomilnacipran—Urethral disorder—Doxorubicin—kidney cancer	9.74e-05	0.000481	CcSEcCtD
Levomilnacipran—Dyspepsia—Capecitabine—kidney cancer	9.64e-05	0.000476	CcSEcCtD
Levomilnacipran—Asthenia—Paclitaxel—kidney cancer	9.58e-05	0.000473	CcSEcCtD
Levomilnacipran—ABCB1—renal system—kidney cancer	9.53e-05	0.0205	CbGeAlD
Levomilnacipran—Decreased appetite—Capecitabine—kidney cancer	9.52e-05	0.00047	CcSEcCtD
Levomilnacipran—Nausea—Gemcitabine—kidney cancer	9.47e-05	0.000467	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Capecitabine—kidney cancer	9.46e-05	0.000467	CcSEcCtD
Levomilnacipran—Fatigue—Capecitabine—kidney cancer	9.44e-05	0.000466	CcSEcCtD
Levomilnacipran—Pruritus—Paclitaxel—kidney cancer	9.44e-05	0.000466	CcSEcCtD
Levomilnacipran—Erythema multiforme—Doxorubicin—kidney cancer	9.4e-05	0.000464	CcSEcCtD
Levomilnacipran—Constipation—Capecitabine—kidney cancer	9.37e-05	0.000462	CcSEcCtD
Levomilnacipran—Eye disorder—Doxorubicin—kidney cancer	9.29e-05	0.000458	CcSEcCtD
Levomilnacipran—Cardiac disorder—Doxorubicin—kidney cancer	9.22e-05	0.000455	CcSEcCtD
Levomilnacipran—Flushing—Doxorubicin—kidney cancer	9.22e-05	0.000455	CcSEcCtD
Levomilnacipran—ABCB1—kidney—kidney cancer	9.22e-05	0.0199	CbGeAlD
Levomilnacipran—Diarrhoea—Paclitaxel—kidney cancer	9.13e-05	0.000451	CcSEcCtD
Levomilnacipran—Angiopathy—Doxorubicin—kidney cancer	9.02e-05	0.000445	CcSEcCtD
Levomilnacipran—ABCB1—cortex of kidney—kidney cancer	8.97e-05	0.0193	CbGeAlD
Levomilnacipran—Gastrointestinal pain—Capecitabine—kidney cancer	8.96e-05	0.000442	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Doxorubicin—kidney cancer	8.96e-05	0.000442	CcSEcCtD
Levomilnacipran—Chills—Doxorubicin—kidney cancer	8.92e-05	0.00044	CcSEcCtD
Levomilnacipran—Dizziness—Paclitaxel—kidney cancer	8.83e-05	0.000436	CcSEcCtD
Levomilnacipran—Mental disorder—Doxorubicin—kidney cancer	8.71e-05	0.00043	CcSEcCtD
Levomilnacipran—Urticaria—Capecitabine—kidney cancer	8.7e-05	0.00043	CcSEcCtD
Levomilnacipran—Abdominal pain—Capecitabine—kidney cancer	8.66e-05	0.000427	CcSEcCtD
Levomilnacipran—Body temperature increased—Capecitabine—kidney cancer	8.66e-05	0.000427	CcSEcCtD
Levomilnacipran—Malnutrition—Doxorubicin—kidney cancer	8.65e-05	0.000427	CcSEcCtD
Levomilnacipran—ABCB1—gonad—kidney cancer	8.55e-05	0.0184	CbGeAlD
Levomilnacipran—Flatulence—Doxorubicin—kidney cancer	8.53e-05	0.000421	CcSEcCtD
Levomilnacipran—Tension—Doxorubicin—kidney cancer	8.49e-05	0.000419	CcSEcCtD
Levomilnacipran—Vomiting—Paclitaxel—kidney cancer	8.49e-05	0.000419	CcSEcCtD
Levomilnacipran—Dysgeusia—Doxorubicin—kidney cancer	8.47e-05	0.000418	CcSEcCtD
Levomilnacipran—Rash—Paclitaxel—kidney cancer	8.42e-05	0.000415	CcSEcCtD
Levomilnacipran—Dermatitis—Paclitaxel—kidney cancer	8.41e-05	0.000415	CcSEcCtD
Levomilnacipran—Headache—Paclitaxel—kidney cancer	8.36e-05	0.000413	CcSEcCtD
Levomilnacipran—Vision blurred—Doxorubicin—kidney cancer	8.15e-05	0.000402	CcSEcCtD
Levomilnacipran—Hypersensitivity—Capecitabine—kidney cancer	8.07e-05	0.000398	CcSEcCtD
Levomilnacipran—Agitation—Doxorubicin—kidney cancer	7.95e-05	0.000392	CcSEcCtD
Levomilnacipran—Nausea—Paclitaxel—kidney cancer	7.93e-05	0.000391	CcSEcCtD
Levomilnacipran—Asthenia—Capecitabine—kidney cancer	7.86e-05	0.000388	CcSEcCtD
Levomilnacipran—Syncope—Doxorubicin—kidney cancer	7.76e-05	0.000383	CcSEcCtD
Levomilnacipran—Pruritus—Capecitabine—kidney cancer	7.75e-05	0.000383	CcSEcCtD
Levomilnacipran—Leukopenia—Doxorubicin—kidney cancer	7.75e-05	0.000382	CcSEcCtD
Levomilnacipran—Palpitations—Doxorubicin—kidney cancer	7.65e-05	0.000377	CcSEcCtD
Levomilnacipran—Loss of consciousness—Doxorubicin—kidney cancer	7.6e-05	0.000375	CcSEcCtD
Levomilnacipran—Convulsion—Doxorubicin—kidney cancer	7.5e-05	0.00037	CcSEcCtD
Levomilnacipran—Diarrhoea—Capecitabine—kidney cancer	7.5e-05	0.00037	CcSEcCtD
Levomilnacipran—Hypertension—Doxorubicin—kidney cancer	7.47e-05	0.000369	CcSEcCtD
Levomilnacipran—Chest pain—Doxorubicin—kidney cancer	7.37e-05	0.000364	CcSEcCtD
Levomilnacipran—Anxiety—Doxorubicin—kidney cancer	7.34e-05	0.000362	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	7.32e-05	0.000361	CcSEcCtD
Levomilnacipran—Dizziness—Capecitabine—kidney cancer	7.24e-05	0.000358	CcSEcCtD
Levomilnacipran—Dry mouth—Doxorubicin—kidney cancer	7.2e-05	0.000356	CcSEcCtD
Levomilnacipran—Infection—Doxorubicin—kidney cancer	7.02e-05	0.000346	CcSEcCtD
Levomilnacipran—Vomiting—Capecitabine—kidney cancer	6.97e-05	0.000344	CcSEcCtD
Levomilnacipran—Shock—Doxorubicin—kidney cancer	6.95e-05	0.000343	CcSEcCtD
Levomilnacipran—Nervous system disorder—Doxorubicin—kidney cancer	6.93e-05	0.000342	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Doxorubicin—kidney cancer	6.91e-05	0.000341	CcSEcCtD
Levomilnacipran—Rash—Capecitabine—kidney cancer	6.91e-05	0.000341	CcSEcCtD
Levomilnacipran—Dermatitis—Capecitabine—kidney cancer	6.9e-05	0.000341	CcSEcCtD
Levomilnacipran—Tachycardia—Doxorubicin—kidney cancer	6.89e-05	0.00034	CcSEcCtD
Levomilnacipran—Headache—Capecitabine—kidney cancer	6.86e-05	0.000339	CcSEcCtD
Levomilnacipran—Skin disorder—Doxorubicin—kidney cancer	6.86e-05	0.000339	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Doxorubicin—kidney cancer	6.83e-05	0.000337	CcSEcCtD
Levomilnacipran—Anorexia—Doxorubicin—kidney cancer	6.73e-05	0.000332	CcSEcCtD
Levomilnacipran—Hypotension—Doxorubicin—kidney cancer	6.6e-05	0.000326	CcSEcCtD
Levomilnacipran—Nausea—Capecitabine—kidney cancer	6.51e-05	0.000321	CcSEcCtD
Levomilnacipran—Insomnia—Doxorubicin—kidney cancer	6.39e-05	0.000315	CcSEcCtD
Levomilnacipran—Paraesthesia—Doxorubicin—kidney cancer	6.34e-05	0.000313	CcSEcCtD
Levomilnacipran—Dyspnoea—Doxorubicin—kidney cancer	6.3e-05	0.000311	CcSEcCtD
Levomilnacipran—Somnolence—Doxorubicin—kidney cancer	6.28e-05	0.00031	CcSEcCtD
Levomilnacipran—Dyspepsia—Doxorubicin—kidney cancer	6.22e-05	0.000307	CcSEcCtD
Levomilnacipran—Decreased appetite—Doxorubicin—kidney cancer	6.14e-05	0.000303	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Doxorubicin—kidney cancer	6.1e-05	0.000301	CcSEcCtD
Levomilnacipran—Fatigue—Doxorubicin—kidney cancer	6.09e-05	0.0003	CcSEcCtD
Levomilnacipran—Constipation—Doxorubicin—kidney cancer	6.04e-05	0.000298	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Doxorubicin—kidney cancer	5.77e-05	0.000285	CcSEcCtD
Levomilnacipran—Urticaria—Doxorubicin—kidney cancer	5.61e-05	0.000277	CcSEcCtD
Levomilnacipran—Body temperature increased—Doxorubicin—kidney cancer	5.58e-05	0.000276	CcSEcCtD
Levomilnacipran—Abdominal pain—Doxorubicin—kidney cancer	5.58e-05	0.000276	CcSEcCtD
Levomilnacipran—Hypersensitivity—Doxorubicin—kidney cancer	5.2e-05	0.000257	CcSEcCtD
Levomilnacipran—Asthenia—Doxorubicin—kidney cancer	5.07e-05	0.00025	CcSEcCtD
Levomilnacipran—Pruritus—Doxorubicin—kidney cancer	5e-05	0.000247	CcSEcCtD
Levomilnacipran—Diarrhoea—Doxorubicin—kidney cancer	4.83e-05	0.000238	CcSEcCtD
Levomilnacipran—Dizziness—Doxorubicin—kidney cancer	4.67e-05	0.00023	CcSEcCtD
Levomilnacipran—Vomiting—Doxorubicin—kidney cancer	4.49e-05	0.000222	CcSEcCtD
Levomilnacipran—Rash—Doxorubicin—kidney cancer	4.45e-05	0.00022	CcSEcCtD
Levomilnacipran—Dermatitis—Doxorubicin—kidney cancer	4.45e-05	0.00022	CcSEcCtD
Levomilnacipran—Headache—Doxorubicin—kidney cancer	4.42e-05	0.000218	CcSEcCtD
Levomilnacipran—Nausea—Doxorubicin—kidney cancer	4.19e-05	0.000207	CcSEcCtD
Levomilnacipran—CYP2C19—Metapathway biotransformation—GSTM1—kidney cancer	3.51e-05	0.000859	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.46e-05	0.000846	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	3.4e-05	0.000832	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL2—kidney cancer	3.38e-05	0.000828	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—CYP1A1—kidney cancer	3.37e-05	0.000826	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	3.37e-05	0.000824	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTT1—kidney cancer	3.36e-05	0.000822	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.33e-05	0.000814	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ACY1—kidney cancer	3.32e-05	0.000814	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.32e-05	0.000812	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GSTM1—kidney cancer	3.27e-05	0.000801	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.25e-05	0.000795	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.25e-05	0.000795	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.25e-05	0.000795	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	3.23e-05	0.00079	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.15e-05	0.000771	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	3.1e-05	0.00076	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3.06e-05	0.000749	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.01e-05	0.000738	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GSTP1—kidney cancer	2.97e-05	0.000727	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ACY1—kidney cancer	2.97e-05	0.000726	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.96e-05	0.000726	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ACY1—kidney cancer	2.89e-05	0.000709	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.87e-05	0.000704	CbGpPWpGaD
Levomilnacipran—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.85e-05	0.000697	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.83e-05	0.000694	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PDHB—kidney cancer	2.82e-05	0.000692	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—POMC—kidney cancer	2.82e-05	0.00069	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ABCB1—kidney cancer	2.81e-05	0.000689	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GSTM1—kidney cancer	2.73e-05	0.000669	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ACY1—kidney cancer	2.73e-05	0.000668	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TP53—kidney cancer	2.72e-05	0.000665	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CCBL1—kidney cancer	2.66e-05	0.000651	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP1A1—kidney cancer	2.59e-05	0.000634	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.53e-05	0.000619	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PDHB—kidney cancer	2.52e-05	0.000618	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—POMC—kidney cancer	2.51e-05	0.000616	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PDHB—kidney cancer	2.46e-05	0.000603	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.4e-05	0.000588	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CCBL1—kidney cancer	2.37e-05	0.000581	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.37e-05	0.000581	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.33e-05	0.00057	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PDHB—kidney cancer	2.32e-05	0.000568	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CCBL1—kidney cancer	2.31e-05	0.000567	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—POMC—kidney cancer	2.31e-05	0.000566	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPAT—kidney cancer	2.3e-05	0.000564	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GLIPR1—kidney cancer	2.3e-05	0.000564	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.3e-05	0.000562	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.27e-05	0.000557	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.25e-05	0.000551	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CCBL1—kidney cancer	2.18e-05	0.000534	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.14e-05	0.000525	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—FH—kidney cancer	2.14e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APRT—kidney cancer	2.14e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.14e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.13e-05	0.000521	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.11e-05	0.000517	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.09e-05	0.000513	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GLIPR1—kidney cancer	2.06e-05	0.000503	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPAT—kidney cancer	2.06e-05	0.000503	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.03e-05	0.000497	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.03e-05	0.000497	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GPC3—kidney cancer	2.01e-05	0.000493	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.01e-05	0.000492	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPAT—kidney cancer	2.01e-05	0.000491	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GLIPR1—kidney cancer	2.01e-05	0.000491	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2e-05	0.00049	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CA2—kidney cancer	1.96e-05	0.00048	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—POMC—kidney cancer	1.93e-05	0.000473	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APRT—kidney cancer	1.91e-05	0.000468	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—FH—kidney cancer	1.91e-05	0.000468	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALAD—kidney cancer	1.91e-05	0.000467	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPAT—kidney cancer	1.89e-05	0.000463	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.89e-05	0.000463	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.87e-05	0.000457	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APRT—kidney cancer	1.87e-05	0.000457	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—FH—kidney cancer	1.87e-05	0.000457	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ST3GAL2—kidney cancer	1.86e-05	0.000456	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.86e-05	0.000456	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.84e-05	0.000451	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALDH1A1—kidney cancer	1.82e-05	0.000446	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.8e-05	0.000441	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GPC3—kidney cancer	1.8e-05	0.00044	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACY1—kidney cancer	1.78e-05	0.000437	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—FH—kidney cancer	1.76e-05	0.000431	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APRT—kidney cancer	1.76e-05	0.000431	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GPC3—kidney cancer	1.75e-05	0.00043	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CA2—kidney cancer	1.75e-05	0.000428	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PGK1—kidney cancer	1.75e-05	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.75e-05	0.000427	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.71e-05	0.000419	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LDHB—kidney cancer	1.71e-05	0.000419	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CA2—kidney cancer	1.71e-05	0.000418	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.7e-05	0.000417	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALAD—kidney cancer	1.7e-05	0.000417	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.68e-05	0.000411	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.66e-05	0.000407	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALAD—kidney cancer	1.66e-05	0.000407	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.65e-05	0.000405	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GPC3—kidney cancer	1.65e-05	0.000405	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.63e-05	0.000398	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.62e-05	0.000398	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.62e-05	0.000397	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.62e-05	0.000397	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.61e-05	0.000394	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CA2—kidney cancer	1.61e-05	0.000394	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.59e-05	0.000388	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.57e-05	0.000384	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALAD—kidney cancer	1.57e-05	0.000384	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.56e-05	0.000382	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PGK1—kidney cancer	1.56e-05	0.000382	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—kidney cancer	1.54e-05	0.000377	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.53e-05	0.000375	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LDHB—kidney cancer	1.53e-05	0.000374	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PGK1—kidney cancer	1.52e-05	0.000372	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC5A3—kidney cancer	1.52e-05	0.000372	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PDHB—kidney cancer	1.52e-05	0.000371	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—POMC—kidney cancer	1.51e-05	0.00037	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.49e-05	0.000366	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LDHB—kidney cancer	1.49e-05	0.000365	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CA9—kidney cancer	1.48e-05	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.45e-05	0.000355	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.43e-05	0.000351	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PGK1—kidney cancer	1.43e-05	0.000351	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CCBL1—kidney cancer	1.43e-05	0.000349	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.42e-05	0.000347	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LDHB—kidney cancer	1.41e-05	0.000344	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTEN—kidney cancer	1.34e-05	0.000329	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.34e-05	0.000328	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CA9—kidney cancer	1.32e-05	0.000324	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.3e-05	0.000319	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.29e-05	0.000317	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CA9—kidney cancer	1.29e-05	0.000317	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.28e-05	0.000313	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CRABP1—kidney cancer	1.26e-05	0.000309	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPAT—kidney cancer	1.24e-05	0.000303	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.24e-05	0.000303	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CA9—kidney cancer	1.22e-05	0.000298	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.21e-05	0.000295	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ITPR2—kidney cancer	1.17e-05	0.000287	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—FH—kidney cancer	1.15e-05	0.000281	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APRT—kidney cancer	1.15e-05	0.000281	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CRABP1—kidney cancer	1.13e-05	0.000276	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.11e-05	0.000271	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CRABP1—kidney cancer	1.1e-05	0.000269	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.08e-05	0.000265	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GPC3—kidney cancer	1.08e-05	0.000265	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.07e-05	0.000262	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTT1—kidney cancer	1.07e-05	0.000262	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ACHE—kidney cancer	1.07e-05	0.000262	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CA2—kidney cancer	1.05e-05	0.000257	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ITPR2—kidney cancer	1.05e-05	0.000256	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CRABP1—kidney cancer	1.04e-05	0.000254	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALAD—kidney cancer	1.02e-05	0.000251	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ITPR2—kidney cancer	1.02e-05	0.00025	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SCARB1—kidney cancer	1.01e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS1—kidney cancer	1e-05	0.000246	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1e-05	0.000245	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PSMD7—kidney cancer	9.83e-06	0.000241	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.77e-06	0.000239	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.65e-06	0.000236	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ITPR2—kidney cancer	9.63e-06	0.000236	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ACHE—kidney cancer	9.55e-06	0.000234	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTT1—kidney cancer	9.55e-06	0.000234	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PIK3CA—kidney cancer	9.47e-06	0.000232	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PGK1—kidney cancer	9.37e-06	0.000229	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.37e-06	0.000229	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTT1—kidney cancer	9.32e-06	0.000228	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ACHE—kidney cancer	9.32e-06	0.000228	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—BCHE—kidney cancer	9.32e-06	0.000228	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC5A5—kidney cancer	9.2e-06	0.000225	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LDHB—kidney cancer	9.19e-06	0.000225	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SCARB1—kidney cancer	9.04e-06	0.000221	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS1—kidney cancer	8.95e-06	0.000219	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—SLC2A1—kidney cancer	8.89e-06	0.000218	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SCARB1—kidney cancer	8.82e-06	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ACHE—kidney cancer	8.78e-06	0.000215	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTT1—kidney cancer	8.78e-06	0.000215	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PSMD7—kidney cancer	8.77e-06	0.000215	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS1—kidney cancer	8.73e-06	0.000214	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.63e-06	0.000211	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PSMD7—kidney cancer	8.56e-06	0.00021	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—BCHE—kidney cancer	8.32e-06	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SCARB1—kidney cancer	8.31e-06	0.000204	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS1—kidney cancer	8.23e-06	0.000202	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC5A5—kidney cancer	8.22e-06	0.000201	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—BCHE—kidney cancer	8.12e-06	0.000199	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PSMD7—kidney cancer	8.07e-06	0.000198	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC5A5—kidney cancer	8.02e-06	0.000196	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CA9—kidney cancer	7.97e-06	0.000195	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.94e-06	0.000194	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—SLC2A1—kidney cancer	7.75e-06	0.00019	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.7e-06	0.000189	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BCHE—kidney cancer	7.65e-06	0.000187	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC5A5—kidney cancer	7.56e-06	0.000185	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.52e-06	0.000184	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTP1—kidney cancer	7.41e-06	0.000182	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.39e-06	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—SLC2A1—kidney cancer	7.3e-06	0.000179	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCB1—kidney cancer	7.02e-06	0.000172	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GSTM1—kidney cancer	6.81e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CRABP1—kidney cancer	6.77e-06	0.000166	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.71e-06	0.000164	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTP1—kidney cancer	6.62e-06	0.000162	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTP1—kidney cancer	6.46e-06	0.000158	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP1A1—kidney cancer	6.46e-06	0.000158	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ITPR2—kidney cancer	6.3e-06	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCB1—kidney cancer	6.26e-06	0.000153	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTP1—kidney cancer	6.09e-06	0.000149	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GSTM1—kidney cancer	6.08e-06	0.000149	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GSTM1—kidney cancer	5.94e-06	0.000145	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.77e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCB1—kidney cancer	5.76e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTT1—kidney cancer	5.74e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACHE—kidney cancer	5.74e-06	0.000141	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP1A1—kidney cancer	5.63e-06	0.000138	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GSTM1—kidney cancer	5.59e-06	0.000137	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SCARB1—kidney cancer	5.44e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS1—kidney cancer	5.38e-06	0.000132	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.31e-06	0.00013	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP1A1—kidney cancer	5.3e-06	0.00013	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PSMD7—kidney cancer	5.28e-06	0.000129	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BCHE—kidney cancer	5e-06	0.000123	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.94e-06	0.000121	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—POMC—kidney cancer	4.82e-06	0.000118	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.77e-06	0.000117	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.74e-06	0.000116	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—POMC—kidney cancer	4.3e-06	0.000105	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—POMC—kidney cancer	4.2e-06	0.000103	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTP1—kidney cancer	3.98e-06	9.75e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—POMC—kidney cancer	3.95e-06	9.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—kidney cancer	3.84e-06	9.41e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCB1—kidney cancer	3.77e-06	9.23e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GSTM1—kidney cancer	3.66e-06	8.96e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.47e-06	8.49e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—kidney cancer	3.43e-06	8.4e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTEN—kidney cancer	3.35e-06	8.21e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—kidney cancer	3.35e-06	8.2e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—kidney cancer	3.15e-06	7.72e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTEN—kidney cancer	2.99e-06	7.32e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTEN—kidney cancer	2.92e-06	7.15e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTEN—kidney cancer	2.75e-06	6.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—POMC—kidney cancer	2.58e-06	6.33e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PIK3CA—kidney cancer	2.36e-06	5.79e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PIK3CA—kidney cancer	2.11e-06	5.17e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—kidney cancer	2.06e-06	5.05e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PIK3CA—kidney cancer	2.06e-06	5.04e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.94e-06	4.75e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTEN—kidney cancer	1.8e-06	4.4e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.27e-06	3.11e-05	CbGpPWpGaD
